Stockscreener 앱 받기
31.47
0.41%
0.13
시간 외 거래:
31.47
전일 마감가:
$31.34
열려 있는:
$31.11
하루 거래량:
692.66K
Relative Volume:
1.24
시가총액:
$1.45B
수익:
$1.08B
순이익/손실:
$-20.76M
주가수익비율:
-68.41
EPS:
-0.46
순현금흐름:
$151.63M
1주 성능:
+1.42%
1개월 성능:
+14.15%
6개월 성능:
-20.55%
1년 성능:
-24.28%
1일 변동 폭
$31.11
$31.98
1주일 범위
$30.32
$31.98
52주 변동 폭
$22.66
$55.74
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
OMCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
31.47 | 1.44B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
274.98 | 45.62B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
71.59 | 12.10B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
63.54 | 11.99B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
87.43 | 7.72B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.52 | 6.16B | 906.14M | -52.62M | 89.62M | -0.3621 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Pharmacy Automation Company Evaluation Report 2025 | BD, Omnicell, and Capsa Healthcare Lead in Medical Technology, Pharmacy Automation, and Medication Management Solutions - Yahoo Finance
Omnicell outlines $40M tariff impact and anticipates $1.105B-$1.155B revenue for 2025 - MSN
Trapped Investors in Omnicell Inc. Await Breakout SignalBull Run & Safe Entry Momentum Stock Tips - beatles.ru
OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance - Yahoo Finance
5 Must-Read Analyst Questions From Omnicell’s Q2 Earnings Call - Yahoo Finance
Did Strong Q2 Results and Improved Profitability Just Shift Omnicell’s (OMCL) Investment Narrative? - simplywall.st
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - TradingView
Omnicell Inc. Bounces Off Moving Average SupportLow Drawdown Real Time Trading Tips Shared - 선데이타임즈
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $55 - 富途牛牛
Piper Sandler lowers Omnicell stock price target to $55 on tariff concerns - Investing.com Nigeria
Omnicell Inc. recovery potential after sell offFree Weekly Stock Watch With Growth Focus - Newser
Best data tools to analyze Omnicell Inc. stockFree Trade Ready Stock Watch for Short Term - Newser
Does Omnicell Inc. show high probability of reboundPredictive System for Long-Term Stock Forecast - Newser
Intraday pattern recognizer results for Omnicell Inc.Portfolio Booster Strategy with Trend Confidence - Newser
Why Omnicell Inc. stock attracts strong analyst attentionEntry and Exit Strategy for Swing Traders - Newser
Can Omnicell Inc. rally from current levelsTriple Digit Gain Opportunity Watchlist - Newser
What makes Omnicell Inc. stock price move sharplyDaily Pick Forecast with Entry Zones - Newser
Price action breakdown for Omnicell Inc.AI Triggered Buy Zone Forecast System - Newser
Evaluating Omnicell Inc. with trendline analysisHigh Conviction Screener with Trend Matching - Newser
How Investors Are Reacting To Omnicell (OMCL) Q2 Revenue Growth and Raised Full-Year Guidance - simplywall.st
Using R and stats models for Omnicell Inc. forecastingWeekly Stock Movement Prediction Watchlist - Newser
Omnicell 2025 Q2 Earnings Strong Performance as Net Income Surges 51% - AInvest
What moving averages say about Omnicell Inc.Momentum Detection with Entry Optimization - Newser
Omnicell’s Earnings Call Highlights Strong Growth and Strategic Wins - The Globe and Mail
Omnicell Management to Meet with KeyBanc - AInvest
Omnicell's Q2 Earnings Call Highlights Strong Growth, Strategic Wins Amid Challenges - AInvest
Omnicell, Inc. (NASDAQ:OMCL) Q2 2025 Earnings Call Transcript - Insider Monkey
Is This the Dip to Buy in Omnicell Inc.Swing Trading Entry Signals Suggest Opportunity Zone - metal.it
What is Omnicell Inc. company’s growth strategyMaximize gains with proven stock analysis - Jammu Links News
What analysts say about Omnicell Inc. stockMassive profits - Jammu Links News
Omnicell Inc. Stock Analysis and ForecastInvest smarter with actionable market insights - Jammu Links News
What are the latest earnings results for Omnicell Inc.Get insider insights into market trends - Jammu Links News
Is Omnicell Inc. a growth stock or a value stockAchieve consistent profits with expert strategies - Jammu Links News
When is Omnicell Inc. stock expected to show significant growthBuild a portfolio for long-term financial success - Jammu Links News
Is it the right time to buy Omnicell Inc. stockInvest smarter with actionable trading signals - Jammu Links News
Omnicell, Inc. (NASDAQ:OMCL) Shares Purchased by XTX Topco Ltd - Defense World
How does Omnicell Inc. compare to its industry peersDouble-digit growth - jammulinksnews.com
What earnings revisions data tells us about Omnicell Inc.RSI and MACD Signal Summary with Trends - Newser
Why is Omnicell Inc. stock attracting strong analyst attentionTremendous return rates - Jammu Links News
What is the dividend policy of Omnicell Inc. stockCapitalize on emerging investment opportunities - Jammu Links News
What markets is SEAL.PRB expanding into Is Omnicell Inc. stock a good long term investment optionAchieve consistent high returns with low risk - Jammu Links News
How strong is Omnicell Inc. company’s balance sheetExceptional financial outcomes - Jammu Links News
Omnicell's Q2 2025 Earnings Highlight Resilience and Growth in Healthcare Automation - AInvest
Omnicell's Q2 2025 Earnings Outperformance: A Strategic Case for Capitalizing on a Resilient Medical Tech Innovator - AInvest
Omnicell Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Arkadios Wealth Advisors Boosts Holdings in Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell's Financial Performance and Growth Prospects Support Buy Rating - AInvest
Omnicell's Strategic Shift to Recurring Revenue: A Pathway to Sustainable Growth in 2025 - AInvest
Omnicell's Q2 2025 Earnings and Strategic Edge in the Autonomous Pharmacy Market: A Case for Long-Term Growth - AInvest
Omnicell, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:OMCL) - Seeking Alpha
Pharmacy Automation Market: Strategic Growth, Competitive Landscape & Long-Term Value for Healthcare Leaders - Barchart.com
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.47%
1.35%
자본화:
|
볼륨(24시간):